Singapore Exchange (SGX) today welcomed the secondary listing of Sri Trang Gloves (Thailand) Public Company Limited on its Mainboard under the stock code “STG”.
Sri Trang Gloves (Thailand) PLC is one of the largest glove manufacturers globally, manufacturing and distributing rubber gloves for a wide range of industries including healthcare and medical. The company currently has three production plants with a total of 145 production lines in Thailand, and its products are exported to more than 140 countries. Listed on the Stock Exchange of Thailand under the stock code “STGT”, it is a subsidiary of Sri Trang Agro-Industry Public Company Limited – a fully integrated natural rubber company and the world’s largest producer and distributor of natural rubber – which is also dual-listed in Thailand and Singapore.
Dr Viyavood Sincharoenkul, Chairman of Executive Committee of Sri Trang Gloves (Thailand) PLC, said, “Today marks another important milestone in Sri Trang Gloves’ journey to deliver the touch of life on a global scale. SGX is an internationally recognised gateway to the global investment community and we believe this listing will further elevate our global profile and enhance shareholders’ value. I thank SGX for their strong support, and extend my appreciation to the professionals who have worked tirelessly towards this day.”
Chew Sutat, Head of Global Sales and Origination, SGX, said, “We are excited to welcome Sri Trang Gloves to SGX. Our partnership with the Sri Trang Group started when Sri Trang Agro-Industry PLC listed on our Mainboard back in 2011. Today’s listing demonstrates the Group’s confidence in SGX as an international fundraising platform. We look forward to partnering with Sri Trang Gloves as it seeks to diversify and broaden its investor base, further increase its profile and visibility in the region, as well as potentially tap international capital in the future.”
The listing of Sri Trang Gloves (Thailand) PLC brings the total number of secondary listings on SGX to 29. It will also join SGX’s healthcare sector, which has a combined market capitalisation of around S$110 billion.
